In the past decade alone, Rob served as Thermo Fisher’s Director of Business Development and Americas Marketing, as well as Senior Vice President of Commercial Operations at Sequenom, and President of Specific Diagnostics. Most recently, Rob was Chief Business Officer of Cardea Bio, that recently sold to Paragraf. Rob currently serves as CEO of Syantra, a groundbreaking cancer and disease detection platform.